Related Experiment Video
Updated: Feb 28, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.5K
No. 185-HIV Screening in Pregnancy
Lisa Keenan-Lindsay1, Mark H Yudin1
1Toronto, ON.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|June 20, 2017
Summary
Screening pregnant women for human immunodeficiency virus (HIV) significantly reduces mother-to-fetus transmission. Early detection and treatment optimize maternal health and prevent vertical transmission.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Public Health
Background:
- Human immunodeficiency virus (HIV) infection poses a significant risk of mother-to-fetus transmission.
- Untreated HIV in pregnant individuals can lead to severe health consequences for both mother and child.
Purpose of the Study:
- To provide evidence-based recommendations for HIV screening in pregnancy.
- To minimize practice variations in HIV screening protocols for obstetric care providers.
- To align screening practices with provincial and territorial guidelines.
Main Methods:
- A comprehensive literature search was conducted using the Cochrane Library and Medline.
- English-language articles related to HIV screening and pregnancy were reviewed.
- Reference lists of identified articles were also examined to ensure thoroughness.
Main Results:
- Screening and treating HIV in pregnancy is crucial for reducing vertical transmission rates.
- Early identification of HIV allows for timely initiation of antiretroviral therapy.
- Confirmation of HIV infection enables optimized long-term health management for the pregnant individual.
Conclusions:
- Implementing standardized HIV screening guidelines in obstetric care is essential.
- Effective screening and treatment protocols significantly decrease the risk of perinatal HIV transmission.
- Routine HIV screening benefits maternal health and facilitates long-term disease management.
